On the other hand, our GWAS discovered a suggestive association with resistant hypertension in the CACNA1D and CYP11B2 regions using a Japanese population, with high prescription rates for calcium channel blockers and angiotensin receptor blockers. The gene discussed is CACNA1D; the disease is Hypertension resistant to conventional therapy.